标题
Loss of Ambra1 promotes melanoma growth and invasion
作者
关键词
-
出版物
Nature Communications
Volume 12, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-05-05
DOI
10.1038/s41467-021-22772-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity
- (2021) Emiliano Maiani et al. NATURE
- Extracellular signal regulated kinase 5 promotes cell migration, invasion and lung metastasis in a FAK-dependent manner
- (2020) Weiwei Jiang et al. Protein & Cell
- The Complex Role of Autophagy in Melanoma Evolution: New Perspectives From Mouse Models
- (2020) Luca Di Leo et al. Frontiers in Oncology
- The autophagy protein Ambra1 regulates gene expression by supporting novel transcriptional complexes
- (2020) Christina Schoenherr et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- AKT1E17K activates focal adhesion kinase and promotes melanoma brain metastasis
- (2019) David A Kircher et al. MOLECULAR CANCER RESEARCH
- Transcriptomic analysis reveals prognostic molecular signatures of stage I melanoma
- (2019) Rohit Thakur et al. CLINICAL CANCER RESEARCH
- Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities
- (2019) Florian Rambow et al. GENES & DEVELOPMENT
- Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress
- (2018) Jennifer Tsoi et al. CANCER CELL
- Genomic and Transcriptomic Analysis Reveals Incremental Disruption of Key Signaling Pathways during Melanoma Evolution
- (2018) A. Hunter Shain et al. CANCER CELL
- Toward Minimal Residual Disease-Directed Therapy in Melanoma
- (2018) Florian Rambow et al. CELL
- AMBRA1 Controls Regulatory T-Cell Differentiation and Homeostasis Upstream of the FOXO3-FOXP3 Axis
- (2018) Juliane Becher et al. DEVELOPMENTAL CELL
- The Role of the Extracellular Matrix and Its Molecular and Cellular Regulators in Cancer Cell Plasticity
- (2018) Valentina Poltavets et al. Frontiers in Oncology
- Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly dividing de‐differentiated state
- (2017) Mohammad Fallahi‐Sichani et al. Molecular Systems Biology
- Targeted agents and immunotherapies: optimizing outcomes in melanoma
- (2017) Jason J. Luke et al. Nature Reviews Clinical Oncology
- The low affinity neurotrophin receptor CD271 regulates phenotype switching in melanoma
- (2017) Gaetana Restivo et al. Nature Communications
- Ambra1 spatially regulates Src activity and Src/FAK-mediated cancer cell invasion via trafficking networks
- (2017) Christina Schoenherr et al. eLife
- Molecular Pathways: Endothelial Cell FAK--A Target for Cancer Treatment
- (2016) M. Roy-Luzarraga et al. CLINICAL CANCER RESEARCH
- PP2A binds to the LIM domains of lipoma-preferred partner through its PR130/B″ subunit to regulate cell adhesion and migration
- (2016) Veerle Janssens et al. JOURNAL OF CELL SCIENCE
- A Transcriptionally Inactive ATF2 Variant Drives Melanomagenesis
- (2016) Giuseppina Claps et al. Cell Reports
- Prognostic Impact of Autophagy Biomarkers for Cutaneous Melanoma
- (2016) Diana Y. L. Tang et al. Frontiers in Oncology
- mTORC1 Activation Blocks BrafV600E-Induced Growth Arrest but Is Insufficient for Melanoma Formation
- (2015) William Damsky et al. CANCER CELL
- Intravital Imaging Reveals How BRAF Inhibition Generates Drug-Tolerant Microenvironments with High Integrin β1/FAK Signaling
- (2015) Eishu Hirata et al. CANCER CELL
- Genomic Classification of Cutaneous Melanoma
- (2015) Rehan Akbani et al. CELL
- Ambra1 at a glance
- (2015) V. Cianfanelli et al. JOURNAL OF CELL SCIENCE
- FAK signaling in human cancer as a target for therapeutics
- (2015) Brian Y. Lee et al. PHARMACOLOGY & THERAPEUTICS
- Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy
- (2015) Claudia Wellbrock et al. Pigment Cell & Melanoma Research
- Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state
- (2015) Annelien Verfaillie et al. Nature Communications
- Atg7 Overcomes Senescence and Promotes Growth of BrafV600E-Driven Melanoma
- (2015) X. Xie et al. Cancer Discovery
- The extracellular matrix modulates the hallmarks of cancer
- (2014) M. W. Pickup et al. EMBO REPORTS
- AMBRA1 links autophagy to cell proliferation and tumorigenesis by promoting c-Myc dephosphorylation and degradation
- (2014) Valentina Cianfanelli et al. NATURE CELL BIOLOGY
- FAK Inhibition Decreases Hepatoblastoma Survival Both In Vitro and In Vivo
- (2014) Lauren A. Gillory et al. Translational Oncology
- Cutaneous melanoma
- (2013) Alexander MM Eggermont et al. LANCET
- mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6
- (2013) Francesca Nazio et al. NATURE CELL BIOLOGY
- Focal adhesion size uniquely predicts cell migration
- (2012) Dong-Hwee Kim et al. FASEB JOURNAL
- Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis
- (2012) L. C. W. Vredeveld et al. GENES & DEVELOPMENT
- Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer
- (2011) T. R. Cox et al. Disease Models & Mechanisms
- The dynamic interaction of AMBRA1 with the dynein motor complex regulates mammalian autophagy
- (2010) Sabrina Di Bartolomeo et al. JOURNAL OF CELL BIOLOGY
- Cancer stem cells versus phenotype-switching in melanoma
- (2010) Keith S. Hoek et al. Pigment Cell & Melanoma Research
- BrafV600E cooperates with Pten loss to induce metastatic melanoma
- (2009) David Dankort et al. NATURE GENETICS
- lumi: a pipeline for processing Illumina microarray
- (2008) P. Du et al. BIOINFORMATICS
- In vivo Switching of Human Melanoma Cells between Proliferative and Invasive States
- (2008) K. S. Hoek et al. CANCER RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started